Journal article
Antithrombotic Therapy in Coronary Ischaemia: The Expanding Role of Low-Molecular-Weight Heparin
Abstract
Low-molecular-weight heparins (LMWHs) have been rigorously evaluated in the management of acute coronary ischaemia. The results of clinical trials suggest that LMWHs are effective in reducing major ischaemic outcomes in patients with unstable angina and non-Q-wave myocardial infarction. In one study, LMWH was shown to be more effective than heparin. The clinical utility of LMWHs given subcutaneously in a fixed-dose without the need for …
Authors
Turpie AGG
Journal
Pathophysiology of Haemostasis and Thrombosis, Vol. 28, No. Suppl 3, pp. 35–42
Publisher
Karger Publishers
Publication Date
1998
DOI
10.1159/000022403
ISSN
1424-8832